Global Candida Infection Testing Market
Healthcare Services

Candida Infection Testing Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the candida infection testing market?

The candida infection testing market has experienced steady growth, projected to increase from $15.69 billion in 2024 to $16.72 billion in 2025 at a CAGR of 6.6%. Growth in the past was driven by a rising incidence of candida infections, greater awareness and diagnostic capabilities, expanded healthcare infrastructure, a surge in hospital-acquired infections, and increased funding for research.

What will be the candida infection testing market size in the future?

The candida infection testing market is poised for strong growth, reaching $21.29 billion by 2029, with a CAGR of 6.2%. This expansion is attributed to emerging candida strains, increased awareness of fungal infections, broader healthcare access, an aging population, and a growing focus on preventive healthcare. Major trends include advancements in molecular diagnostics, the integration of AI and machine learning, the rise of digital health technologies, and the development of personalized medicine.

Get your candida infection testing market report here!

https://www.thebusinessresearchcompany.com/report/candida-infection-testing-global-market-report

What main drivers are fueling expansion in the candida infection testing market?

The increasing incidence of yeast infections is driving the growth of the candida infection testing market. Yeast infections result from candida overgrowth, commonly affecting the mouth, genitals, and skin, leading to itching and irritation. Factors like bacterial imbalances, weakened immunity, and hormonal changes contribute to these infections. Candida infection testing ensures accurate diagnosis and appropriate treatment. According to GOV.UK, the rate of bloodstream infections caused by yeast in England was 4.0 per 100,000 in 2022, reflecting a 4% rise from 2021. Therefore, the rising occurrence of yeast infections is accelerating the candida infection testing market.

What key areas define the segmentation of the global candida infection testing market?

The candida infection testingmarket covered in this report is segmented –

1) By Type: Invasive Candidiasis, Candidemia

2) By Test Type: Vaginal pH Test, Nucleic Acid Amplification Testing (NAAT), Microbiome Test

3) By Application: Hospital, Laboratory

Subsegments:

1) By Invasive Candidiasis: Tissue Biopsy Testing, Urine Culture Testing, Blood Culture Testing

2) By Candidemia: Blood Tests, Serological Testing, Molecular Testing

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19356&type=smp

Who are the dominant players expanding their reach in the candida infection testing market?

Major companies operating in the candida infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Cepheid, Randox Laboratories Ltd., Meridian Bioscience Inc., DiaSorin S.p.A., Sekisui Diagnostics LLC, Enzo Biochem Inc., T2 Biosystems Inc., Aidian Oy, SafeCare LLC, CHROMagar, HK Biotek Inc., Health Testing Centers LLC, Accesa Labs LLC, Private MD Labs LLC

How are evolving market trends shaping candida infection testing Strategies?

Leading firms in the candida infection testing market are currently putting their efforts into creating technologically sophisticated solutions like a fully automated PCR swift test that can detect candida, with the intention of escalating diagnostic precision and improving the health outcomes of patients. A fully automated PCR quick test for detecting candida is a cutting-edge diagnostic instrument that utilises PCR technology to promptly and accurately determine the existence of Candida species in clinical samples. As an example, in May 2024, Bosch Healthcare Solutions GmbH, a medical technology manufacturing company based in Germany, introduced a PCR test for candida auris detection on the Vivalytic platform, providing fully automated, swift testing at the point of care within just an hour. This sophisticated test enables swift screenings and starkly contrasts with earlier culture methods that would take one to three days in centralized laboratories, thus postponing diagnosis and treatment. Specifically designed to be utilised in clinical settings, this test proves beneficial to high-risk patients as it allows for a timely diagnosis and combat against the severe health complications that C. auris infections often lead to.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19356

Which regions are emerging as leaders in the candida infection testing market?

North America was the largest region in the candida infection testing market in 2024. The regions covered in the candida infection testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Pseudomonas Aeruginosa Infection Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pseudomonas-aeruginosa-infection-treatment-global-market-report

High Level Disinfection Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/high-level-disinfection-services-global-market-report

Infection Control Supplies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: